Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
MEDIFICE from Chastre, company number BE0757632950, closed financial year 2025 with a result of € 29,898 after tax. For that financial year MEDIFICE recorded a gross margin of € 94,403 and equity of € 15,115. Compared with financial year 2024, the result moved from € 1,249 to € 29,898. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 28, 2026.
€ 15,115
▲ € 29,898 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 29,898
▲ € 28,649 vs 2024
Profit after tax over the fiscal year.
€ 41,890
▼ 6% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -26,885.
People and assets in 2025
€ 17,378
▼ 21% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 942,524
▼ 5% vs 2024
€ 49,630 is repaid this year. At this pace the long-term loan is gone in ≈ 19 years.
€ 4,082
▼ 94% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -2,682 | € -7,797 | € 41,301 | € 94,403 | ▲ 129% |
| Profit after taxes | € -4,830 | € -20,985 | € 1,249 | € 29,898 | ▲ € 28,649 |
| Equity | € 4,952 | € -16,033 | € -14,783 | € 15,115 | ▲ € 29,898 |
| Total debts | € 191,601 | € 935,661 | € 1,061,783 | € 950,452 | ▼ 10% |
| Cash | € 24,413 | € 1,128 | € 44,694 | € 41,890 | ▼ 6% |
| Land & buildings | € 171,340 | € 621,777 | € 920,601 | € 905,038 | ▼ 2% |
| Retained profit | € -37,048 | € -58,033 | € -56,783 | € -26,885 | ▲ € 29,898 |
| Bank debt | € 155,000 | € 895,000 | € 988,213 | € 942,524 | ▼ 5% |
| Balance sheet total | € 196,553 | € 919,628 | € 1,047,000 | € 965,567 | ▼ 8% |
Key figures of MEDIFICE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDIFICE?
What happened at MEDIFICE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 29,898 (▲ € 28,649 vs 2024). filed late Source: NBB ↗
- Paul Ronse became a director. NBB
- New establishment in Chastre. KBO
- Start of the company according to the CBE. KBO
- Alizée Detiffe became a director. NBB
- Chloé Aujoulat became a director. NBB
In short
From € 4,830 loss in 2022 to € 29,898 profit in 2025.
Best year ever: 2025, with € 29,898 profit.
Management
Behind MEDIFICE are Alizée Detiffe, Chloé Aujoulat and Paul Ronse. Alizée Detiffe is also behind Dr Alizée Detiffe. Chloé Aujoulat is also behind Docteur Aujoulat.
Directors
According to the 2025 annual accounts
since 2020
since 2020
Paul Ronse
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Rue du Dessus 60
1450 Chastre
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0757.632.950
- VAT number
- BE 0757.632.950
- Registered office
- Rue du Dessus 60, 1450 Chastre
- Names & denominations
- MEDIFICE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 October 2020
- Peppol
- Not registered
- Contact
- [email protected]